Publications by authors named "Molteni L"

Article Synopsis
  • Cenobamate (CNB) is a newly approved antiseizure medication for adults with focal-onset seizures who haven’t responded to at least two other treatments, but it may interact with other drugs requiring careful monitoring.
  • This study presents an innovative method using Volumetric Absorptive Microsampling (VAMS) for accurately measuring CNB levels in patients, validated according to rigorous guidelines.
  • The results show the new method is reliable, with strong accuracy and precision, and stable for up to 15 days, making it a promising option for therapeutic drug monitoring in CNB treatment.
View Article and Find Full Text PDF

Aims: To assess the effects of IDegLira on glucometric indices deriving from intermittently scanned Continuous Glucose Monitoring (isCGM) in patients with type 2 diabetes (T2D).

Methods: Retrospective, observational, cohort, multi-center, "pre - post" study. All adults consecutively identified in the medical records who started treatment with IDegLira, and for whom an isCGM report before and after the initiation of IDegLira was available were included in the study.

View Article and Find Full Text PDF

Background: Blinding is thought to minimise expectancy effects and biases in double-blind randomised-controlled trials (RCTs). However, whether blinding integrity should be assessed and reported remains debated. Furthermore, it is unknown whether blinding failure influences the outcome of RCTs in anxiety disorders.

View Article and Find Full Text PDF

Objective: People with mental illness are overrepresented throughout the criminal justice system. In Italy, the Judicial Psychiatric Hospitals are now on the edge of their closure in favor of small-scale therapeutic facilities (REMS). Therefore, when patients end their duty for criminal behaviors, their clinical management moves back to the outpatient psychiatric centers.

View Article and Find Full Text PDF

Interoception is defined as the sense of the internal state of the body. Dysfunctions in interoception are found in several mental disorders, including trauma-related conditions. Mindfulness-Based Interventions (MBIs) have been shown to influence interoceptive processes.

View Article and Find Full Text PDF

Background: Anxiety disorders are highly prevalent and socio-economically costly. Novel pharmacological treatments for these disorders are needed because many patients do not respond to current agents or experience unwanted side effects. However, a barrier to treatment development is the variable and large placebo response rate seen in trials of novel anxiolytics.

View Article and Find Full Text PDF

Background: Compared to Immediate-Release (IR) metformin, Extended-Release (ER) metformin reduces side effects and pill burden while improving adherence; however, there is little real-life data on patient satisfaction with this innovative formulation to guide physicians toward a more holistic approach.

Objective: Our goal is to train general practitioners on holistic patient management, with the aim of increasing patient satisfaction and treatment adherence, reducing side effects, and improving quality of life in patients with poor tolerance to metformin-IR.

Materials And Methods: We designed an educational program for physicians called SlowDiab, aimed at establishing a holistic patient approach.

View Article and Find Full Text PDF

Cenobamate (CNB) is a new anti-seizure medication (ASM) recently introduced in clinical practice after approval by the FDA and EMA for the add-on treatment of focal onset seizures in adult patients. Although its mechanism of action has not been fully understood, CNB showed promising clinical efficacy in patients treated with concomitant ASMs. The accessibility of CNB could pave a way for the treatment of refractory or drug-resistant epilepsies, which still affect at least one-third of the patients under pharmacological treatment.

View Article and Find Full Text PDF

Chemotherapy-induced peripheral neuropathy (CIPN) commonly arises as a side effect of diverse cancer chemotherapy treatments. This condition presents symptoms such as numbness, tingling, and altered sensation in patients, often accompanied by neuropathic pain. Pathologically, CIPN is characterized by an intensive "dying-back" axonopathy, starting at the intra-epidermal sensory innervations and advancing retrogradely.

View Article and Find Full Text PDF

Objective: Depression represents one of the most severe psychiatric disorders, characterized by low mood episodes, as well as loss of interest. Major Depressive Episodes (MDE) treatment relies primarily on monoaminergic prescriptions. However, although the presence of many antidepressant medications, their efficacy is still partial.

View Article and Find Full Text PDF

Levodopa (L-DOPA) treatment, combined with the administration of dopa-decarboxylase inhibitors (DDCIs), is still the most effective symptomatic treatment of Parkinson's disease (PD). Although its efficacy in the early stage of the disease has been confirmed, its complex pharmacokinetics (PK) increases the variability of the intra-individual motor response, thus amplifying the risk of motor/non-motor fluctuations and dyskinesia. Moreover, it has been demonstrated that L-DOPA PK is strongly influenced by several clinical, therapeutic, and lifestyle variables (e.

View Article and Find Full Text PDF

We report on a compact and versatile time-domain spectrometer operating in the THz spectral region from 0.2 to 2.5 THz based on ultrafast Yb:CALGO laser and photo-conductive antennas.

View Article and Find Full Text PDF

Objective: health care workers (HCWs) represent a vulnerable group in the COVID-19 pandemic, given the exposure to greater risk and higher levels of work-related stress. Neurofeedback (NF) has shown to be effective in the treatment of stress-related symptoms. We aimed to assess the effectiveness of an alpha-increase NF protocol for the treatment of acute stress symptoms in HCWs exposed to the COVID-19 pandemic.

View Article and Find Full Text PDF

Amyotrophic lateral sclerosis (ALS) is an incurable motor neuron disease whose etiology remains unresolved; nonetheless, mutations of superoxide dismutase 1 (SOD1) have been associated with several variants of ALS. Currently available pharmacologic interventions are only symptomatic and palliative in effect; therefore, there is a pressing demand for more effective drugs. This study examined potential therapeutic effects of growth hormone secretagogues (GHSs), a large family of synthetic compounds, as possible candidates for the treatment of ALS.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined changes in microRNA (miRNA) levels in the knee synovial fluid of patients with osteoarthritis (OA) and anterior cruciate ligament (ACL) tears using real-time quantitative polymerase chain reaction (RT-qPCR).
  • A total of twelve specific miRNAs associated with bone and cartilage pathology were analyzed from samples of 30 ACL tear patients and 18 OA patients, revealing varying expression levels among them.
  • Notably, some miRNAs, like miR-30b-5p, showed higher expression in chronic cases compared to acute ACL tears, indicating that these miRNAs could serve as potential biomarkers for understanding joint conditions.
View Article and Find Full Text PDF
Article Synopsis
  • Amyotrophic lateral sclerosis (ALS) is caused by the death of neurons and involves a mix of genetic, molecular, and environmental factors; currently, only two drugs are approved for treatment.
  • Ghrelin, a hormone linked to growth hormone secretion, shows potential neuroprotective effects that may be useful in treating ALS, although its natural form is unstable and not prevalent in circulation.
  • Synthetic compounds known as growth hormone secretagogues (GHS) can mimic ghrelin's effects and have shown promise in providing neuroprotection, with some being safely evaluated for use in humans, indicating potential as therapies for ALS.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the relationship between personality traits and the effectiveness of anti-CGRP monoclonal antibodies in treating migraines.
  • Non-responders to the treatment exhibited significant personality traits such as disinhibition, heightened depressivity, and distractibility compared to responders.
  • The findings suggest that certain rigid personality traits may make migraine treatment less effective, highlighting the need for a more personalized approach in managing migraines.
View Article and Find Full Text PDF

Treatment of 4-(2-hydroaminoalkylidenyl)- and 4-(2-hydroxyalkylidenyl)-substituted isoxazol-5(4)-ones with catalytic amounts of [RuCl(-cymene)], without any additive, afforded pyrazole- and isoxazole-4-carboxylic acids, respectively. The presence of an intramolecular H-bond in these substrates was the key to divert the classical mechanism toward a ring-opening non-decarboxylative path that is expected to generate a vinyl Ru-nitrenoid intermediate, the cyclization of which affords the rearranged products. A gram scale protocol demonstrated the synthetic applicability of this transformation.

View Article and Find Full Text PDF

Combined AntiRetroviral Treatments (cARTs) used for HIV infection may result in varied metabolic complications, which in some cases, may be related to patient genetic factors, particularly microRNAs. The use of monozygotic twins, differing only for HIV infection, presents a unique and powerful model for the controlled analysis of potential alterations of miRNAs regulation consequent to cART treatment. Profiling of 2578 mature miRNA in the subcutaneous (SC) adipose tissue and plasma of monozygotic twins was investigated by the GeneChip® miRNA 4.

View Article and Find Full Text PDF

A dimerization/cyclization reaction of 2-benzylamino-phenols for the direct synthesis of the oxazolo-phenoxazine skeleton is reported. The reaction occurs under copper catalysis in the presence of hypervalent iodine(III), giving selectively the 5-oxazolo[4,5-]phenoxazine compounds. The cascade process, which allows the conversion of the substrates into the tetracyclic products, involves three C-H functionalization steps.

View Article and Find Full Text PDF

Introduction:: Acute respiratory distress syndrome (ARDS) is an acute form of diffuse lung injury characterized by (i) an intense inflammatory response, (ii) increased pulmonary vascular permeability, and (iii) the loss of respiratory pulmonary tissue. In this article we explore the therapeutic potential of hexarelin, a synthetic hexapeptide growth hormone secretagogue (GHS), in an experimental model of ARDS. Hexarelin has anti-inflammatory properties and demonstrates cardiovascular-protective activities including the inhibition of cardiomyocyte apoptosis and cardiac fibrosis, both of which may involve the angiotensin-converting enzyme (ACE) system.

View Article and Find Full Text PDF

Background: Panic disorder (PD) is a prevalent and impairing anxiety disorder with previous reports suggesting that the longer the condition remains untreated, the greater the likelihood of nonresponse. However, patients with PD may wait for years before receiving a guideline-recommended pharmacological treatment. The widespread prescription of benzodiazepines (BDZ) for managing anxiety symptoms and disorders might delay the administration of pharmacotherapy according to guidelines (eg, selective serotonin reuptake inhibitors, SSRIs).

View Article and Find Full Text PDF

The Pd(II)-catalyzed reaction of -allyl-2-aminophenols in the presence of PhI(OCOR) as the oxidant resulted in an alkoxyacyloxylation process, with the formation of functionalized dihydro-1,4-benzoxazines. The reaction performed in the absence of palladium catalyst switched to an intramolecular Diels-Alder reaction (IMDA) pathway, which was the result of an oxidative dearomatization of the 2-aminophenol, nucleophilic addition, and Diels-Alder reaction cascade, highlighting the role of the oxidant as both a nucleophilic donor and an oxidizing agent.

View Article and Find Full Text PDF

Purpose: Emergency rooms (ERs) are usually the first point of contact with mental health services for adolescents with Substance Use Disorders (SUDs). However, only a minority of them receives proper treatment and follow-up indications, increasing the risk of relapses and poor prognosis. In this perspective, we sought to characterize and compare socio-demographic and clinical characteristics of adolescents with vs without SUDs accessing the ER, assessing potential differences in terms of discharge instructions.

View Article and Find Full Text PDF